文献速递关节外科创伤骨科

双动组件在移位型股骨颈骨折患者中的成本效益

Cost-effectiveness of dual-mobility components in patients with displaced femoral neck fractures.
PubMed 文献 · Bone Joint J · 2021-01-01

本研究从加拿大医保支付方角度构建五年决策分析模型,评估75至79岁移位型股骨颈骨折患者使用双动全髋关节置换(DM-THA)相较传统单动全髋关节置换(SB-THA)的成本效益。结果显示DM-THA估计增量成本效益比为每质量调整生命年46556加元(27074英镑),但敏感性分析显示其在所有年龄组前两年均不具成本效益,80岁及以上患者在任何时间点均不具成本效益。作者认为对于80岁以下患者,DM-THA可能具有成本效益,但未来研究将有助于确定模型中的不良事件发生率是否成立。

要点

  • DM-THA估计ICER为每QALY 46556加元(27074英镑),基线病例显示具有成本效益。
  • 敏感性分析显示DM-THA在所有年龄组前两年均不具成本效益。
  • 80岁以下患者在5至15年时间点DM-THA具有成本效益,80岁及以上患者在任何时间点均不具成本效益。

核心结论

  • 作者认为对于80岁以下移位型股骨颈骨折患者,使用DM-THA组件相较SB-THA可能具有成本效益。
  • 未来研究将有助于确定模型中的不良事件发生率是否成立。
  • 作者建议外科医生应继续运用临床判断并考虑患者个体生理年龄和脱位危险因素。

研究设计与样本

  • 本研究为成本效益分析,从加拿大医保支付方角度建立成本和效益模型。
  • 基线病例为75至79岁患者,时间跨度为五年。
  • 采用单因素敏感性分析和概率敏感性分析评估基线模型结论的稳健性。

主要发现

  • DM-THA估计增量成本效益比(ICER)为每质量调整生命年(QALY)46556加元(27074英镑)。
  • 敏感性分析显示DM-THA在所有年龄组前两年均不具成本效益。
  • DM-THA对于80岁以下患者在5至15年时间点具有成本效益,但对于80岁及以上患者在任何时间点均不具成本效益。
  • 在基线病例中,DM-THA要在十年时具有成本效益,其相较SB-THA必须将脱位风险降低至少62%。
  • 概率敏感性分析显示DM-THA在基线病例中具有成本效益的概率为58%。

临床怎么用

  • 作者认为对于80岁以下移位型股骨颈骨折患者,使用DM-THA可能具有成本效益。
  • 作者建议外科医生应继续运用临床判断并考虑患者个体生理年龄和脱位危险因素。

局限性

  • 未来研究将有助于确定模型中的不良事件发生率是否成立。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

AIMS: Total hip arthroplasty (THA) with dual-mobility components (DM-THA) has been shown to decrease the risk of dislocation in the setting of a displaced neck of femur fracture compared to conventional single-bearing THA (SB-THA). This study assesses if the clinical benefit of a reduced dislocation rate can justify the incremental cost increase of DM-THA compared to SB-THA. METHODS: Costs and benefits were established for patients aged 75 to 79 years over a five-year time period in the base case from the Canadian Health Payer's perspective. One-way and probabilistic sensitivity analysis assessed the robustness of the base case model conclusions. RESULTS: DM-THA was found to be cost-effective, with an estimated incremental cost-effectiveness ratio (ICER) of CAD $46,556 (£27,074) per quality-adjusted life year (QALY). Sensitivity analysis revealed DM-THA was not cost-effective across all age groups in the first two years. DM-THA becomes cost-effective for those aged under 80 years at time periods from five to 15 years, but was not cost-effective for those aged 80 years and over at any timepoint. To be cost-effective at ten years in the base case, DM-THA must reduce the risk of dislocation compared to SB-THA by at least 62%. Probabilistic sensitivity analysis showed DM-THA was 58% likely to be cost-effective in the base case. CONCLUSION: Treating patients with a displaced femoral neck fracture using DM-THA components may be cost-effective compared to SB-THA in patients aged under 80 years. However, future research will help determine if the modelled rates of adverse events hold true. Surgeons should continue to use clinical judgement and consider individual patients' physiological age and risk factors for dislocation. Cite this article: Bone Joint J 2021;103-B(12):1783-1790.

来源:Bone Joint J,查看原文。版权归原作者所有。

引用

  1. Montgomery S, Bourget-Murray J, You DZ, et al. Cost-effectiveness of dual-mobility components in patients with displaced femoral neck fractures. Bone Joint J. 2021. PMID: 34847713. doi:10.1302/0301-620X.103B12.BJJ-2021-0495.R2

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。